Published in AIDS Weekly, April 25th, 2005
Bristol-Myers Squibb has provided, and will continue to provide, millions of dollars in relief to ADAPs during the next 2 years by supplying the company's complete line of HIV medications and other select products at a reduced cost. This extension will help ensure thousands of low-income, underinsured and uninsured people living with HIV/AIDS maintain access to life-saving antiretroviral medications.
"Bristol-Myers Squibb is committed to ensuring people...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.